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Visual pathway abnormalities were found 
in most multiple sclerosis patients despite 
history of previous optic neuritis
Anormalidades nas vias visuais foram encontradas na maior parte dos pacientes com 
esclerose múltipla independentemente da história de neurite óptica
Stella Maris Costa Castro1, Alfredo Damasceno2, Benito Pereira Damasceno2, Jose Paulo de Vasconcellos1, 
Fabiano Reis3, Josie Naomi Iyeyasu1, Keila Monteiro de Carvalho1
Multiple sclerosis (MS) is a multifocal and relapsing 
demyelinating disease of the central nervous system with 
a variable clinical course and pathological features. Optic 
neuritis (ON) is the most common isolated event, but any 
part of the visual pathway could be affected, from the reti-
na to the primary visual cortex. It is estimated that 40% of 
MS patients experience ON as their first clinical demyelin-
ating event and up to 80% during the course of their illness1. 
In post-mortem2 and magnetic resonance imaging (MRI)3 
studies in MS patients, optic radiation (OR) lesions were 
common findings, however, symptomatic retrochiasmal in-
volvement is seldom found4.
Visual field (VF) deficits correlate with MRI in neurologi-
cal diseases that affect OR5. This pathway conveys axons from 
the lateral geniculate nucleus to the primary visual cortex and 
injury in this location may impair vision. Standard achromatic 
perimetry as the Humphrey VF has been used to identify and 
localize VF defects in most patients with neuro-ophthalmic 
diseases6. In the Optic Neuritis Treatment Trial Study, 8.9% of 
patients showed a binocular retrochiasmal type of field defect 
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ABSTRACT
Objective: It was to investigate visual field (VF) abnormalities in a group of multiple sclerosis (MS) patients in the remission phase and the 
presence of magnetic resonance imaging (MRI) lesions in the optic radiations. Methods: VF was assessed in 60 participants (age range 
20–51 years): 35 relapsing-remitting MS patients [20 optic neuritis (+), 15 optic neuritis (-)] and 25 controls. MRI (3-Tesla) was obtained in 
all patients. Results: Visual parameters were abnormal in MS patients as compared to controls. The majority of VF defects were diffuse. All 
patients except one had posterior visual pathways lesions. No significant difference in lesion number, length and distribution was noted 
between patients with and without history of optic neuritis. One patient presented homonymous hemianopsia. Conclusion: Posterior visual 
pathway abnormalities were found in most MS patients despite history of previous optic neuritis.
Key words: magnetic resonance imaging, optic neuritis, visual pathways, multiple sclerosis.
RESUMO
Objetivo: Foi analisar o campo visual (CV) de um grupo de pacientes com esclerose múltipla (EM) na fase remissiva e a presença de lesões 
nas imagens de ressonância magnética (MRI) na radiação óptica. Método: O CV foi estudado em 60 participantes (faixa etária de 20–51 anos): 
35 pacientes EM remitente-recorrente: [20 neurite óptica (+), 15 neurite óptica (-)] e 25 controles. Foram obtidas MRI (3-Tesla) de todos os 
pacientes. Resultados: Havia alterações visuais nos pacientes com EM quando comparados aos controles. A maioria apresentava defeitos 
difusos de CV. Todos os pacientes, à exceção de um, apresentaram lesões nas vias visuais posteriores. Não foi observada diferença significa-
tiva quanto a número, extensão e distribuição das lesões entre os pacientes com e sem história de neurite óptica. Um paciente apresentou 
hemianopsia homônima. Conclusão: Anormalidades nas via visuais posteriores foram encontradas na maior parte dos pacientes com EM 
independentemente da história de neurite óptica.
Palavras-Chave: imagem por ressonância magnética, neurite óptica, vias visuais, esclerose múltipla.
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at least once during the first year of follow up, but specific anal-
ysis of the visual pathway alteration was not performed7.
Our aim was to investigate asymptomatic VF defects in a 
group of MS patients in the remission phase and assess the 
presence of MRI lesions of the posterior visual pathways.
METHODS
Subjects
We studied 35 patients (28 women, 7 men), mean age 
28 years (range 20 to 51 years), with clinically definite relaps-
ing-remitting MS diagnosed according to revised McDonald 
criteria8 attending our outpatient clinic of the MS centre, 
at UNICAMP University Hospital, Brazil, between October 
2009  to June 2011. They were classified in two groups ac-
cording to the presence of previous history of one or more 
episodes of acute optic neuritis, as determined by self-in-
dividual and physician report, and confirmed by medical 
record review: (I)  the MS-ON (+) group, comprised of 20 
patients with positive history of unilateral or bilateral ON; 
and (II) the MS-ON (–) group, including 15 patients with no 
previous ON history. At the time the assessments were per-
formed, researchers were blinded to the previous optic neu-
ritis history of MS patients. The last episode of ON was at 
least six months prior to data collection. The patients had 
no concomitant ocular diseases or systemic conditions that 
could affect the visual system other than ON/MS. We also 
studied 25 healthy subjects (19 women, 6 men; mean age 
30 years, range 20 to 50 years) for comparison. Written in-
formed consent was obtained from all patients and volun-
teers before study entry. Procedures adhered to the tenets 
of Declaration of Helsinki, and the protocol was approved 
by the local Ethics Committee.
Clinical assessment
All patients underwent a comprehensive ophthalmic ex-
amination of each eye, including refractions prior to vision 
testing, slit lamp examination, fundoscopy, intraocular pres-
sure, pupil light reflex and ocular motor examinations. We 
assessed measurements of monocular visual acuity (at 3 m) 
using an Early Treatment Diabetic Retinopathy Study 
(ETDRS) chart. Monocular color vision was rated with the 
first 17  plates of Ishihara pseudoisochromatic (24 plates, 
2001 edition). For the visual parameters, right and left eye 
measurements were averaged for the subsequent statistical 
analyses. Patients  were examined through a standardized 
neurological procedure, and the level of disability was deter-
mined using the Expanded Disability Status Scale (EDSS)9. 
Controls had no history of neurologic or ophthalmic disease 
apart from refractive error of no more than four diopters of 
spherical equivalent and one diopter of astigmatic refractive 
error, with best-corrected and logMAR acuities of 0.0 (equiva-
lent to 20/20) or better.
Perimetry
Achromatic standard perimetry was performed with the 
Humphrey Field Analyzer II, model 750, Carl Zeiss Meditec 
software version A-10 (Humphrey, San Leandro, EUA), using 
the 24-2 Threshold Test with Swedish interactive threshold 
algorithm fast strategy, foveal threshold on. Criteria for ab-
normalities were: VF indices (global mean deviation or pat-
tern standard deviation) that were at the p<0.05 probability 
level or worse, abnormal Glaucoma Hemifield Test by the in-
strument’s software or pattern of loss consistent with ocu-
lar abnormalities. VF was considered unreliable if the false-
positive, false-negative and fixation index exceeded 20%. We 
measured mean deviation, pattern standard deviation, foveal 
threshold and pattern of VF loss, and compared them with 
a reference field derived from control data provided by the 
manufacturer. Each VF was judged to be either normal or ab-
normal, with all VF chart information used. Diffuse VF loss 
was characterized by visual loss distributed throughout the 
field without focal defect. Localized defects were character-
ized by visual sensitivity worse in one or more areas of the 
field, with severity depending on the depth and spatial extent 
of the abnormality10. Binocular VF defects were considered as 
homonymous when a cluster of three or more serial abnor-
mal points was located along the vertical meridian and there 
were no additional scattered abnormal points that obscured 
the hemianopic pattern11.
MRI acquisition
All the patients were scanned by a cranial MRI (3-Tesla 
Intera; Philips Medical System, Best, the Netherlands) us-
ing a contrast-enhanced T1-weighted spin-echo and a dual-
echo sequence for T2-weighted turbo spin-echo sequence, 
axial fast fluid-attenuated inversion recovery (FLAIR) and 
double inversion recovery (DIR). All lesions were identi-
fied using standard anatomical landmarks, localized on ax-
ial  slices and identified into OR with FLAIR and/or DIR 
axial images. High signal-intensity brain lesions in the OR 
with a size of ≥3 mm were counted and scored in the follow-
ing manner: group 1=zero, group 2=one lesion, and group 
3=two or more lesions. These lesions were classified accord-
ing their size and scored 0–2 depending on the visualiza-
tion in one axial plane (group 0=no lesion, group 1=3 until 
10 mm, group 2=more than 10 mm).
Statistical analyses
Statistical analyses were performed using SPSS 13.0 for 
Windows (SPSS, Chicago, IL, USA). Means of the visual acu-
ity, Humphrey VF indices (dB) and Ishihara plates’ errors 
were created from each subject. Non-parametric tests were 
used for comparisons between two groups (Mann-Whitney 
U Test) and three groups (Kruskal-Wallis). A conservative 
threshold of p<0.05 was considered statistically significant. 
We performed the Bonferroni procedure for comparisons be-
tween three groups.
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RESULTS
Clinical fi ndings
All patients were in the remission phase of the disease 
(median 14 months, range 5 to 144 months from the last re-
lapse), and presented median visual acuity equal 0.0 logMAR 
(range 0.1 to -0.15). Th e median time of the last ON episode 
was 3 years (range 6 to 166 months). None of the patients had 
been treated with corticosteroids in the three months before 
evaluation and all were using immunomodulatory drugs. 
None had aff erent pupillary defect. 
Visual assessment
All controls had normal VF. MS patients had mainly dif-
fuse pattern (52%), followed by normal (34%) and localized 
(14%) VF (the arcuate defect was the most common type). 
Only one patient had a pattern of binocular defect, a partial 
homonymous hemianopsia. As compared to controls, MS-
ON (+) patients had worse visual acuity (p<0.05) and worse 
color vision (p<0.001). Th e MS-ON (-) group had worse color 
vision compared to controls (p<0.01). Th e Humphrey VF in-
dices of mean deviation, pattern standard deviation and fo-
veal threshold were worse in MS subgroups than in controls 
(p<0.01) (Table). 
Post-chiasmal visual pathways
All but one patient presented OR and/or primary visual 
cortex lesions. One patient with left partial homonymous 
hemianopsia had one lesion in the right primary visual cor-
tex with sparing of the occipital pole (Figure).
Table. Demographic and clinical data of multiple sclerosis patients and controls.
Summary of clinical data MS-ON (+) – (n=20)mean±SD (range)
MS-ON (-) – (n=15)
mean±SD (range)
Controls (n=25)
mean±SD (range)
Female sex 17 11 19
Age (years) 30±8 (20–51) 28±7 (20–40) 30±8 (20–50)
Disease duration (years) 7.9±5.5 (1.6–23.0)a 4.0±3.6 (<1–12) -
EDSS score 2.0±1.0 (1.0–4.5) 1.8±0.9 (1.0–4.0) -
Visual acuity (logMAR) -0.00±0.06 (-0.15–0.1)b -0.03±0.04 (-0.1–0.0) -0.05±0.05 (-0.1–0.0)
Humphrey VF – MD (dB) -4.02±3.10 (-13.80–0.12)b -2.53±1.78 (-5.49–0.35)b -0.60±0.80 (-1.88–1.34)
Humphrey VF – PSD (dB) 2.76±1.87 (1.28–8.10) b 2.07±0.97 (1.07–4.87)b 1.36±0.21 (0.85–1.80)
Fovea threshold (dB) 35.30±1.81 (32.0–39.0)b 35.90±1.65 (33.0–38.5)b 37.22±1.02 (35.0–39.5)
Ishihara error score 3.00±3.8 (0.0–16.0)b 0.73±0.86 (0.0–3.0)a, b 0.22±0.43 (0.0–1.5)
n (%) n (%) n (%)
Lenght of lesios 3.0–10.0 mm 12 (60) 9 (60) -
Multiple lesions 18 (90) 12 (80) -
Bilateral distribution 17 (85) 12 (80) -
ap signifi cant value between multiple sclerosis groups; bp signifi cant value between multiple sclerosis subgroup and controls with Bonferroni correction.
EDSS: Expanded Disability Status Scale; ON (+): optic neuritis history present; ON (-): no optic neuritis history; VF: visual fi eld; MD: mean deviation; PSD: pattern 
standard deviation; SD: standard deviation; dB: decibel.
Figure. (A) Axial fl uid-attenuated inversion recovery and (B) 
Axial double inversion recovery magnetic resonance imaging 
show lesion on right primary visual cortex. 24-2 Swedish 
interactive threshold algorithm fast Humphrey visual fi eld test 
shows a partial left homonymous hemianopsia in (C) left eye 
and (D) right eye. 
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worse mean deviation and pattern standard deviation on the VF 
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DISCUSSION
Our results confirm that visual pathways are often abnor-
mal during the remission phase of relapsing MS patients even 
in those without previous history of visual affection.
In this study, abnormal visual fields were found in most 
patients with MS. The visual function was worse in both MS 
subgroups compared to controls. These data confirmed pre-
vious reports12-14, suggesting that chronic axon damage can 
occur in spite of episodes of acute ON, although stronger cor-
relation was found in eyes with history of ON.
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pathway on MRI (in 96% of the patients). This has already been 
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es through the periventricular white matter that typically is af-
fected by demyelinating lesions8. There are several issues that 
explain the disparity between radiological and clinical mani-
festation in the posterior visual pathways: small lesions of the 
optic radiations and cortex may exist without demonstrable 
VF defect whereas large lesions are more likely to cause symp-
tomatic field loss4. Optical radiation consists of large axons with 
thick myelin sheaths and low fiber density with wide translucent 
space18, different from the optic nerve fibers which are concen-
trated in a relatively small volume. This distribution of the fibers, 
the redundancy and plasticity of the posterior pathway, the pos-
sibility of demyelination without detectable axonal conduction 
deficit and the tendency for inflammation in MS to be centered 
around venules and not fiber tracts19, all these factors may ex-
plain the difficulty to correlate neuroimaging and clinical data. 
Abnormalities of VF is a characteristic of optic neuritis and 
the increase of value of mean deviation, a signal of recovery7. 
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multiple sclerosis as the etiologic cause21. 
There are some papers demonstrating a correlation be-
tween retinal and postgeniculate structures. Using diffusion 
tensor tractography, it was found an association between MRI 
indices along OR and visual disability at low contrast22, and vi-
sual disability was found to be related to T2-weighted lesion 
load in the entire brain, occipital lobe white matter and OR23. 
In our series, in contrast to these studies, there were no such 
clinical-radiologic correlations. Longer and greater number of 
lesions in the OR and worse VF indices were found only in the 
MS-ON (+) although there is no difference in lesion load be-
tween the two MS subgroups. It is more likely that the worsen-
ing VF indices mainly reflects the damage to the optic nerves as 
we can see by optical coherence tomography study12,13,24, rather 
than residual relationship between retinal and OR lesions.
This study has some limitations. Conventional MRI has 
insufficient sensitivity and specificity to reveal the true ex-
tent of pathological changes occurring in MS, as normal ap-
pearing white matter may harbor different abnormalities, 
as seen in non-conventional MRI and pathological works25. 
Another limitation is that we did not assess retinal structur-
al integrity with optical coherence tomography and visual 
evoked potential because these instruments were not avail-
able at our center at the time the study was started.
In conclusion, the present study demonstrates that posterior 
visual pathway abnormalities are found in most MS patients de-
spite the history of previous ON, but it has failed to demonstrate 
a link between posterior visual pathways lesions and VF indices.
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